S&P 500   3,204.96 (-0.67%)
DOW   26,772.78 (-0.36%)
S&P 500   3,204.96 (-0.67%)
DOW   26,772.78 (-0.36%)
S&P 500   3,204.96 (-0.67%)
DOW   26,772.78 (-0.36%)
S&P 500   3,204.96 (-0.67%)
DOW   26,772.78 (-0.36%)
Log in

NASDAQ:CTXRCitius Pharmaceuticals News Headlines

$1.16
-0.04 (-3.33 %)
(As of 07/16/2020 10:09 AM ET)
Add
Compare
Today's Range
$1.15
Now: $1.16
$1.20
50-Day Range
$0.86
MA: $1.05
$1.45
52-Week Range
$0.40
Now: $1.16
$1.97
Volume66,322 shs
Average Volume6.18 million shs
Market Capitalization$52.42 million
P/E RatioN/A
Dividend YieldN/A
Beta1.93

Headlines

Citius Pharmaceuticals (NASDAQ CTXR) News Headlines

Source:
DateHeadline
Citius Pharmaceuticals Brings on Myron S. Czuczman, M.D. as Chief Medical Officer (CMO) and Executive Vice PresidentCitius Pharmaceuticals Brings on Myron S. Czuczman, M.D. as Chief Medical Officer (CMO) and Executive Vice President
finance.yahoo.com - July 14 at 1:50 PM
Citius Pharmaceuticals Inc (NASDAQ:CTXR) Expected to Announce Earnings of -$0.11 Per ShareCitius Pharmaceuticals Inc (NASDAQ:CTXR) Expected to Announce Earnings of -$0.11 Per Share
www.americanbankingnews.com - July 10 at 11:48 AM
Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1%Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1%
finance.yahoo.com - June 30 at 12:40 PM
Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole PetallidesCitius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
finance.yahoo.com - June 29 at 9:28 AM
Thinking about buying stock in Citius Pharmaceuticals, Aytu Bioscience, Applied DNA Sciences, Royal Caribbean Cruises, or American Airlines?Thinking about buying stock in Citius Pharmaceuticals, Aytu Bioscience, Applied DNA Sciences, Royal Caribbean Cruises, or American Airlines?
www.marketwatch.com - June 26 at 1:00 PM
Citius: FDA Issues Guidelines To Study IPSC-derived MSCs To Treat COVID-19 PatientsCitius: FDA Issues Guidelines To Study IPSC-derived MSCs To Treat COVID-19 Patients
www.nasdaq.com - June 26 at 1:00 PM
Citius Pharma rallies on accelerated review prospects for stem cells for COVID-19Citius Pharma rallies on accelerated review prospects for stem cells for COVID-19
seekingalpha.com - June 26 at 1:00 PM
Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
finance.yahoo.com - June 26 at 1:00 PM
Analysts Anticipate Citius Pharmaceuticals Inc (NASDAQ:CTXR) to Announce ($0.09) Earnings Per ShareAnalysts Anticipate Citius Pharmaceuticals Inc (NASDAQ:CTXR) to Announce ($0.09) Earnings Per Share
www.americanbankingnews.com - June 23 at 12:19 PM
Citius Pharmaceuticals to Deliver Virtual Presentation at the Life Sciences Investor ForumCitius Pharmaceuticals to Deliver Virtual Presentation at the Life Sciences Investor Forum
finance.yahoo.com - June 22 at 3:22 PM
Citius Receives Positive FDA Feedback on Its Submitted Plan to Study Catheter Compatibility for Mino-Lok® TherapyCitius Receives Positive FDA Feedback on Its Submitted Plan to Study Catheter Compatibility for Mino-Lok® Therapy
finance.yahoo.com - June 2 at 10:34 AM
Citius Announces Expanded Access Program for Investigational Phase 3 Mino-Lok®Citius Announces Expanded Access Program for Investigational Phase 3 Mino-Lok®
finance.yahoo.com - May 26 at 8:43 AM
Citius Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesCitius Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - May 18 at 2:49 PM
CTXR Citius Pharmaceuticals, Inc. Common StockCTXR Citius Pharmaceuticals, Inc. Common Stock
www.nasdaq.com - May 16 at 9:02 AM
Should You Be Concerned About Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Historical Volatility?Should You Be Concerned About Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Historical Volatility?
finance.yahoo.com - May 15 at 9:03 AM
Citius Announces $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq RulesCitius Announces $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
finance.yahoo.com - May 14 at 12:53 PM
Citius Announces Data on NoveCite Mesenchymal Stem Cells (NC-MSCs) to be Presented at the AmericanCitius Announces Data on NoveCite Mesenchymal Stem Cells (NC-MSCs) to be Presented at the American
www.prnewswire.com - May 13 at 11:52 AM
Citius Announces Data on NoveCite Mesenchymal Stem Cells (NC-MSCs) to be Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingCitius Announces Data on NoveCite Mesenchymal Stem Cells (NC-MSCs) to be Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
finance.yahoo.com - May 13 at 11:52 AM
Citius Pharmaceuticals Issues May 2020 Shareholder LetterCitius Pharmaceuticals Issues May 2020 Shareholder Letter
finance.yahoo.com - May 12 at 9:50 AM
Citius Pharmaceuticals Inc.Citius Pharmaceuticals Inc.
www.barrons.com - May 7 at 4:21 PM
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) in COVID-19Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) in COVID-19
finance.yahoo.com - April 27 at 2:14 PM
Citius Pharmaceuticals, Inc. Common Stock (CTXR) Option ChainCitius Pharmaceuticals, Inc. Common Stock (CTXR) Option Chain
www.nasdaq.com - April 18 at 10:51 PM
Citius Signs Exclusive Option with Novellus to...Citius Signs Exclusive Option with Novellus to...
www.benzinga.com - April 1 at 4:32 PM
Why Citius Pharmaceuticals Is Trading Higher TodayWhy Citius Pharmaceuticals Is Trading Higher Today
www.benzinga.com - April 1 at 4:32 PM
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
finance.yahoo.com - April 1 at 4:32 PM
Citius Pharmaceuticals Announces Publication in Antimicrobial Agents and Chemotherapy Journal of Positive Preclinical Results for Mino-Lok® in Rapidly Eradicating Candida AurisCitius Pharmaceuticals Announces Publication in Antimicrobial Agents and Chemotherapy Journal of Positive Preclinical Results for Mino-Lok® in Rapidly Eradicating Candida Auris
finance.yahoo.com - March 26 at 3:10 PM
Citius Pharmaceuticals to Deliver Virtual Presentation at the Spring Investor SummitCitius Pharmaceuticals to Deliver Virtual Presentation at the Spring Investor Summit
finance.yahoo.com - March 18 at 1:57 PM
Heres Why We Worry About Citius Pharmaceuticalss (NASDAQ:CTXR) Cash Burn SituationHere's Why We Worry About Citius Pharmaceuticals's (NASDAQ:CTXR) Cash Burn Situation
finance.yahoo.com - March 16 at 8:48 AM
Here's Why We Worry About Citius Pharmaceuticals's (NASDAQ:CTXR) Cash Burn SituationHere's Why We Worry About Citius Pharmaceuticals's (NASDAQ:CTXR) Cash Burn Situation
finance.yahoo.com - March 16 at 8:47 AM
Citius Pharmaceuticals Inc: Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York CityCitius Pharmaceuticals Inc: Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City
www.finanznachrichten.de - March 3 at 5:18 PM
Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York CityCitius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City
finance.yahoo.com - March 3 at 5:18 PM
Citius Pharmaceuticals to Present at the 2020 LD Micro Virtual ConferenceCitius Pharmaceuticals to Present at the 2020 LD Micro Virtual Conference
finance.yahoo.com - February 26 at 8:23 AM
Citius Pharmaceuticals Cites Independent Estimates of Total Available World Market for Mino-Lok®Citius Pharmaceuticals Cites Independent Estimates of Total Available World Market for Mino-Lok®
finance.yahoo.com - February 25 at 8:53 AM
Citius Pharmaceuticals to Present at Noble Capital Markets' 16th Annual Investor ConferenceCitius Pharmaceuticals to Present at Noble Capital Markets' 16th Annual Investor Conference
finance.yahoo.com - February 10 at 9:07 AM
Citius Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal TrialCitius Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
www.prnewswire.com - February 4 at 12:05 PM
Citius Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementsCitius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
finance.yahoo.com - February 3 at 10:49 AM
Biotech Companies Think Big with Specialization - Fighting Deadly Bacteria and VirusesBiotech Companies Think Big with Specialization - Fighting Deadly Bacteria and Viruses
finance.yahoo.com - January 27 at 12:28 PM
Citius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal TrialCitius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial
finance.yahoo.com - December 19 at 8:19 AM
Citius Pharmaceuticals to Present at the 12th Annual LD Micro Main EventCitius Pharmaceuticals to Present at the 12th Annual LD Micro Main Event
finance.yahoo.com - December 4 at 9:03 AM
Citius Pharmaceuticals Issues Corporate UpdateCitius Pharmaceuticals Issues Corporate Update
finance.yahoo.com - November 8 at 8:38 AM
Citius Pharmaceuticals to Present at the 5th Annual Dawson James Small Cap Growth ConferenceCitius Pharmaceuticals to Present at the 5th Annual Dawson James Small Cap Growth Conference
finance.yahoo.com - October 24 at 8:24 AM
Citius Pharmaceuticals to Present at the MicroCap RodeoCitius Pharmaceuticals to Present at the MicroCap Rodeo
www.benzinga.com - October 15 at 1:02 PM
Citius Reaches First Interim Analysis Milestone for Mino-Lok® Pivotal TrialCitius Reaches First Interim Analysis Milestone for Mino-Lok® Pivotal Trial
finance.yahoo.com - October 7 at 1:25 PM
Citius Provides Update on Activities From IDWeek 2019Citius Provides Update on Activities From IDWeek 2019
finance.yahoo.com - October 3 at 8:22 AM
Insider Buying: The Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Executive Chairman & Secretary Just Bought US$2.0m Worth Of SharesInsider Buying: The Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Executive Chairman & Secretary Just Bought US$2.0m Worth Of Shares
finance.yahoo.com - September 28 at 4:26 PM
Citius Announces Pricing of $7.0 Million Underwritten Offering Priced At-the-MarketCitius Announces Pricing of $7.0 Million Underwritten Offering Priced At-the-Market
finance.yahoo.com - September 25 at 5:40 PM
BRIEF-Citius Announces Change To Primary Endpoint In Mino-Lok Phase 3 StudyBRIEF-Citius Announces Change To Primary Endpoint In Mino-Lok Phase 3 Study
www.msn.com - September 5 at 11:19 AM
Citius Pharma up 8% on lower efficacy bar in late-stage Mino-Lok studyCitius Pharma up 8% on lower efficacy bar in late-stage Mino-Lok study
seekingalpha.com - September 5 at 11:19 AM
Citius Announces Change To Primary Endpoint In Mino-Lok® Phase 3 StudyCitius Announces Change To Primary Endpoint In Mino-Lok® Phase 3 Study
finance.yahoo.com - September 4 at 9:46 AM
Citius Provides Developmental Plans for Mino-WrapCitius Provides Developmental Plans for Mino-Wrap
finance.yahoo.com - July 30 at 8:41 AM
This page was last updated on 7/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.